Good morning. I’m Charlie Mahtesian. Get in touch.

Illumina sees new pharma interest, even as its business suffers several hits from NIH funding and a DOJ settlement.

Chinese artificial intelligence model developer Zhipu AI, whose progress has attracted Washington’s scrutiny and caught ...

The city, formally a special zone of China, retains much of its international culture and customs, making it an attractive test bed for Chinese companies.